Interferon beta trialled as COVID-19 treatment

15 January, 2021 | Posted in: ,

Interferon beta, a well known treatment amongst the multiple sclerosis (MS) community, is being trialled as a treatment option for people with coronavirus. The hope is it will stimulate the immune system, priming cells to be ready to fight off viruses. The aim is to treat patients who are hospitalised with COVID-19 in order to […]

Continue Reading »

Data published by Wilmington Healthcare, Parkinson’s Concierge and Parkinson’s Academy highlight the impact of the COVID-19 Pandemic and NHS contact to people with Parkinson’s

30 September, 2020 | Posted in: ,

The COVID-19 pandemic has made a dramatic difference to the way in which people with Parkinson’s (PwP) see their Parkinson’s team. A new summary of data by healthcare intelligence provider Wilmington Healthcare, Parkinson’s Concierge and the transformative educator Parkinson’s Academy has highlighted the huge impact COVID-19 has had on people with Parkinson’s and Parkinson’s services. […]

Continue Reading »

8 out of 10 report their dementia worsened during lockdown according to charity investigation

31 July, 2020 | Posted in: ,

Eight out of 10 people living with dementia have experienced a deterioration in their symptoms during lockdown, announced Alzheimer’s Society yesterday.  The charity, working with One Dementia Voice, have carried out an investigation of just under 2,000 individuals affected by dementia, and the findings are shocking. Aware anecdotally of the challenges of those with dementia […]

Continue Reading »

Neurology Academy during the COVID-19 pandemic

22 July, 2020 | Posted in: ,

On 23rd March 2020, our society was changed overnight. The announcement of a UK-wide lockdown due to the coronavirus pandemic meant a drastic change to everyone’s lives, and to our health service.  Health professionals were redeployed to frontline services, regular clinics for diagnosis and review were suspended and frantic attempts to use telehealth and other […]

Continue Reading »

Huge impact on people living with dementia as COVID-related care home mortality rates are released

8 July, 2020 | Posted in:

Over 60,000 care home residents died in the past few months, said a report released on 7th July by the Office for National Statistics (ONS). Of those residents who died, 49.5% had a recorded pre-existing condition of dementia and Alzheimer disease. These shocking statistics suggest that almost 30,000 people living with dementia or Alzheimer’s disease […]

Continue Reading »

Essential neurorehabilitation in the aftermath of COVID-19

6 July, 2020 | Posted in:

The impact of coronavirus on our health service has been highly documented, but with the first wave passed, the burden has not lifted, but altered, in the form of rehabilitation. Earlier this week, we highlighted an article in Reuters which has since been echoed in multiple publications – the long-term implications of COVID-19 on a […]

Continue Reading »

The long term implications of COVID-19 are becoming apparent

29 June, 2020 | Posted in:

We have become increasingly aware, over the past few months, that the symptoms of COVID-19 are wider ranging than initially thought.  A recent article in Reuters has highlighted the full extent of this, and called into question whether we are prepared, as a society, for the rehabilitative process that will be needed by many who […]

Continue Reading »